354 related articles for article (PubMed ID: 17450170)
1. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
4. Medical cannabis vs. synthetic cannabinoids: What does the future hold?
Bolognini D; Ross RA
Clin Pharmacol Ther; 2015 Jun; 97(6):568-70. PubMed ID: 25761845
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids in depressive disorders.
Poleszak E; Wośko S; Sławińska K; Szopa A; Wróbel A; Serefko A
Life Sci; 2018 Nov; 213():18-24. PubMed ID: 30290188
[TBL] [Abstract][Full Text] [Related]
6. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
7. Bipolar disorder and the endocannabinoid system.
Arjmand S; Behzadi M; Kohlmeier KA; Mazhari S; Sabahi A; Shabani M
Acta Neuropsychiatr; 2019 Aug; 31(4):193-201. PubMed ID: 31159897
[TBL] [Abstract][Full Text] [Related]
8. Role of Cannabinoid Signaling in Cardiovascular Function and Ischemic Injury.
Rorabaugh BR; Guindon J; Morgan DJ
J Pharmacol Exp Ther; 2023 Dec; 387(3):265-276. PubMed ID: 37739804
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids in the management of difficult to treat pain.
Russo EB
Ther Clin Risk Manag; 2008 Feb; 4(1):245-59. PubMed ID: 18728714
[TBL] [Abstract][Full Text] [Related]
10. Effects of Cannabinoids on T-cell Function and Resistance to Infection.
Eisenstein TK; Meissler JJ
J Neuroimmune Pharmacol; 2015 Jun; 10(2):204-16. PubMed ID: 25876735
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids and the Cardiovascular System in Health and Disease.
O'Sullivan SE
Handb Exp Pharmacol; 2015; 231():393-422. PubMed ID: 26408169
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids, inflammation, and fibrosis.
Zurier RB; Burstein SH
FASEB J; 2016 Nov; 30(11):3682-3689. PubMed ID: 27435265
[TBL] [Abstract][Full Text] [Related]
13. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
Karimian Azari E; Kerrigan A; O'Connor A
J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids in the Cardiovascular System.
Ho WSV; Kelly MEM
Adv Pharmacol; 2017; 80():329-366. PubMed ID: 28826540
[TBL] [Abstract][Full Text] [Related]
15. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.
Ranieri R; Marasco D; Bifulco M; Malfitano AM
Recent Pat CNS Drug Discov; 2016; 10(2):157-177. PubMed ID: 27184693
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoids: the hidden side of Spice drugs.
Pintori N; Loi B; Mereu M
Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
Horváth B; Mukhopadhyay P; Haskó G; Pacher P
Am J Pathol; 2012 Feb; 180(2):432-42. PubMed ID: 22155112
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?
Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
Neurotox Res; 2016 Jan; 29(1):173-96. PubMed ID: 26353844
[TBL] [Abstract][Full Text] [Related]
19. The effects of cannabinoids on the endocrine system.
Borowska M; Czarnywojtek A; Sawicka-Gutaj N; Woliński K; Płazińska MT; Mikołajczak P; Ruchała M
Endokrynol Pol; 2018; 69(6):705-719. PubMed ID: 30618031
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases.
Carbone F; Mach F; Vuilleumier N; Montecucco F
Curr Med Chem; 2014; 21(35):4046-58. PubMed ID: 25245379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
